A retrievable immune scaffold reveals a 5–7 week presymptomatic window for tracking type 1 diabetes progression, long before blood sugar tests turn positive. Study: Longitudinal monitoring of type 1 diabetes progression to disease onset. Image credit: Halfpoint/Shutterstock.com A recent study published in Science Advances described the application of subcutaneous microporous scaffolds, viz., immunological niches (INs), for … Read more
During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and viruses from self-antigens that are expressed by cells of the body. If not, the immune system can mistakenly attack its own cells, causing lasting damage to tissue and potential long-term disease. New research from the University of Chicago … Read more
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson’s disease. Their new research reveals how a protein in brain cells may drive Parkinson’s onset-and offers a possible explanation for why Parkinson’s is much more common in men. In recent years, LJI scientists have found increasing evidence that … Read more